Key result
Transvenous CIED leads are linked to a low 1.6% PE incidence with higher subsequent mortality.
Cohort (n=5,646)
No
Clinical pulmonary embolism occurs with a low incidence in patients with transvenous CIED leads, and the majority of cases are associated with other established risk factors.
Answers are grounded in this paper and cite their sources.
Low PE incidence after transvenous CIED leads does not support routine screening; leaves open whether targeted interventions reduce the observed mortality risk.
BACKGROUND: Cardiac implantable electronic devices (CIEDs) are commonly associated with transvenous lead-related thrombi that can cause pulmonary embolism (PE). METHODS AND RESULTS: We retrospectively evaluated all patients with transvenous CIED leads implanted at Mayo Clinic Rochester between 1 January 2000, and 25 October 2010. Pulmonary embolism outcomes during follow-up were screened using diagnosis codes and confirmed with imaging study reports. Of 5646 CIED patients (age 67.3 ± 16.3 years, 64% men, mean follow-up 4.69 years) 88 developed PE (1.6%), incidence 3.32 [95% confidence interval (CI) 2.68-4.07] per 1000 person-years [men: 3.04 (95% CI 2.29-3.96) per 1000 person-years; women: 3.81 (95% CI 2.72-5.20) per 1000 person-years]. Other than transvenous CIED lead(s), 84% had another established risk factor for PE such as deep vein thrombosis (28%), recent surgery (27%), malignancy (25%), or prior history of venous thromboembolism (15%). At the time of PE, 22% had been hospitalized for ≥ 48 h, and 59% had been hospitalized in the preceding 30 days. Pulmonary embolism occurred in 22% despite being on systemic anticoagulation therapy. Out of 88 patients with PE, 45 subsequently died, mortality rate 93 (95% CI 67-123) per 1000 person-years (hazard ratio 2.0, 95% CI 1.5-2.7, P < 0.0001). CONCLUSIONS: Though lead-related thrombus is commonly seen in patients with transvenous CIED leads, clinical PE occurs with a low incidence. It is possible that embolism of lead thrombus is uncommon or emboli are too small to cause consequential pulmonary infarction.
No takes yet. Share an insight, caveat, or question.
Noheria et al. (2015) conducted a cohort in Transvenous cardiac implantable electronic device leads (n=5,646). Transvenous cardiac implantable electronic device leads was evaluated on Pulmonary embolism. Transvenous CIED leads were associated with a low 1.6% incidence of clinical pulmonary embolism, though PE occurrence increased subsequent mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: